The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers
Molecular Therapy2011Vol. 20(4), pp. 749–758
Citations Over TimeTop 10% of 2011 papers
Kelley A. Parato, Caroline J. Breitbach, Fabrice Le Bœuf, Jiahu Wang, Chris Storbeck, Carolina S. Ilkow, Jean‐Simon Diallo, Theresa Falls, Joseph K. Burns, Vanessa da Silva Garcia, Femina Kanji, Laura Evgin, Kang Hu, Francois Paradis, Shane Knowles, Tae-Ho Hwang, Barbara C. Vanderhyden, Rebecca C. Auer, David H. Kirn, John C. Bell
Related Papers
- → The mechanisms of genetically modified vaccinia viruses for the treatment of cancer(2015)31 cited
- → Fluorescent Tagged Vaccinia Virus Genome Allows Rapid and Efficient Measurement of Oncolytic Potential and Discovery of Oncolytic Modulators(2020)19 cited
- → Anti‐tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies(2014)8 cited
- Advances of Oncolytic Vaccinia Virus for the Treatment of Tumor(2012)
- → Oncolytic vaccinia virus: a promising agent for cancer treatment(2016)